Kwang-Soo Kim Selected Research

dopamine beta hydroxylase deficiency

3/2011	Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase.
3/2002	Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kwang-Soo Kim Research Topics

Disease

29	Parkinson Disease (Parkinson's Disease) 02/2022 - 02/2005
20	Neoplasms (Cancer) 04/2021 - 04/2005
9	Schizophrenia (Dementia Praecox) 08/2015 - 04/2002
8	Aphakia 01/2022 - 02/2005
5	Breast Neoplasms (Breast Cancer) 03/2020 - 01/2015
4	Bipolar Disorder (Manic Depressive Psychosis) 08/2015 - 02/2004
4	Teratoma (Teratoid Tumor) 08/2013 - 06/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 01/2003
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2010 - 12/2006
3	Neuroblastoma 07/2006 - 10/2003
2	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2019
2	Hypoxia (Hypoxemia) 01/2021 - 08/2013
2	Triple Negative Breast Neoplasms 11/2019 - 01/2017
2	Cognitive Dysfunction 01/2019 - 01/2013
2	Anhedonia 01/2017 - 03/2014
2	Dyskinesias (Dyskinesia) 07/2015 - 07/2007
2	Seizures (Absence Seizure) 01/2015 - 11/2014
2	dopamine beta hydroxylase deficiency 03/2011 - 03/2002
1	Neurodevelopmental Disorders 11/2021
1	Retinal Neovascularization 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Cytokine Release Syndrome 12/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 10/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Hypertrophy 01/2017
1	Obesity 01/2017
1	Neuroinflammatory Diseases 01/2016

Drug/Important Bio-Agent (IBA)

13	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 02/2002
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
6	Messenger RNA (mRNA)IBA 01/2017 - 10/2003
5	Pharmaceutical PreparationsIBA 10/2019 - 10/2002
5	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 03/2013 - 02/2005
4	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 02/2005
4	CytokinesIBA 04/2021 - 12/2012
4	Dopamine beta-HydroxylaseIBA 03/2011 - 03/2002
4	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2004 - 04/2002
3	MicroRNAs (MicroRNA)IBA 10/2019 - 04/2005
3	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2017 - 02/2005
3	Leucine (L-Leucine)FDA Link 01/2016 - 06/2008
3	Phosphotransferases (Kinase)IBA 01/2016 - 06/2008
2	UbiquitinIBA 11/2021 - 12/2015
2	Neuroprotective AgentsIBA 01/2020 - 01/2016
2	Peptide Elongation Factors (Elongation Factor)IBA 01/2019 - 12/2015
2	Member 2 Group A Nuclear Receptor Subfamily 4IBA 01/2019 - 01/2015
2	LipopolysaccharidesIBA 01/2018 - 01/2016
2	Oxidopamine (6 Hydroxydopamine)IBA 01/2016 - 07/2015
2	Amyloid beta-PeptidesIBA 01/2016 - 01/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2015 - 05/2014
2	gamma-Aminobutyric Acid (GABA)IBA 11/2014 - 09/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2013 - 03/2011
2	Mixed Function Oxygenases (Monooxygenases)IBA 08/2012 - 03/2011
2	Transcription Factors (Transcription Factor)IBA 09/2008 - 12/2006
2	Dopamine Agonists (Dopamine Agonist)IBA 07/2007 - 04/2004
2	Dihydroxyphenylalanine (Dopa)IBA 07/2007 - 02/2005
2	Olanzapine (Zyprexa)FDA Link 04/2004 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2003 - 05/2003
2	Lymphotoxin-alpha (Lymphotoxin)IBA 05/2003 - 02/2003
2	InterleukinsIBA 04/2003 - 04/2002
2	Interleukin-10 (Interleukin 10)IBA 04/2003 - 04/2002
2	Antipsychotic Agents (Antipsychotics)IBA 02/2003 - 05/2002
2	Mirtazapine (Rexer)FDA LinkGeneric 10/2002 - 04/2002
1	Ligases (Synthetase)IBA 11/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	InterferonsIBA 01/2021
1	pyrazoleIBA 03/2020
1	prostaglandin A1 (PGA1)IBA 01/2020
1	Alprostadil (Muse)FDA LinkGeneric 01/2020
1	Chimeric Antigen ReceptorsIBA 11/2019
1	Cadherins (E-Cadherin)IBA 11/2019
1	Antimalarials (Antimalarial Agents)IBA 10/2019
1	Chloroquine (Aralen)FDA LinkGeneric 10/2019
1	Conditioned Culture MediaIBA 10/2019
1	Amodiaquine (Camoquin)FDA Link 01/2019
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2019
1	Poly I-CIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 06/2017
1	Biological ProductsIBA 01/2017
1	Sterol Regulatory Element Binding Protein 1IBA 01/2017
1	Bromodeoxyuridine (BrdU)IBA 01/2017
1	Vascular Endothelial Growth Factor CIBA 01/2017
1	antineoplaston A10 (A 10)IBA 01/2017
1	ClaudinsIBA 10/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Orphan Nuclear ReceptorsIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016

Therapy/Procedure

18	Therapeutics 01/2022 - 09/2004
11	Transplantation 01/2020 - 06/2006
5	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2022 - 08/2013
4	Immunotherapy 04/2021 - 11/2019
3	Cell Transplantation 01/2020 - 03/2006
1	Homologous Transplantation 01/2021
1	Intra-Arterial Infusions 01/2021